4//SEC Filing
WINDSOR JAMES BRIAN 4
Accession 0001213900-20-023891
CIK 0001733413other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 6:13 PM ET
Size
5.4 KB
Accession
0001213900-20-023891
Insider Transaction Report
Form 4
WINDSOR JAMES BRIAN
DirectorChief Science Officer
Transactions
- Award
Stock Options (Right to Buy)
2020-08-24+20,000→ 159,429 totalExercise: $13.65→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Each Option shall vest and first become exercisable as follows: one-quarter of the Option shall vest and first become exercisable on August 24, 2021 and the remainder of the Option shall vest and first become exercisable in 12 equal quarterly installments commencing on November 24, 2021.
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
Related Parties
1- filerCIK 0001790933
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 6:13 PM ET
- Size
- 5.4 KB